ArticlePlastic and reconstructive surgery. Global open2026
Clavicular Augmentation With Poly-d,l-lactic Acid (Juvelook GLAM) using Cannula.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prominent clavicles are an increasingly requested aesthetic goal in East Asian patients. Poly‑d,l‑lactic acid (PDLLA) is a collagen‑stimulating injectable, but clinical data for clavicular augmentation remain limited. Methods: In this prospective, single‑arm case series, 44 East Asian women underwent bilateral clavicular augmentation with PDLLA (Juvelook GLAM, VAIM Inc., Korea) delivered via blunt cannula in the subcutaneous plane. Outcomes included adverse events, Global Aesthetic Improvement Scale ratings from standardized photographs, a 5‑point satisfaction scale, and objective projection change measured with 3‑dimensional imaging at 3 and 6 months. Results: No major complications were observed through 6 months. Transient bruising (19.4%) and swelling (25.8%) resolved spontaneously. Mean clavicular projection increased by +1.8 ± 0.6 mm at 3 months and +1.6 ± 0.5 mm at 6 months ( Conclusions: In this uncontrolled early‑outcomes series, PDLLA clavicular augmentation was feasible and was associated with high short‑term satisfaction and a modest but measurable increase in projection. Larger controlled studies with longer follow‑up and validated patient‑reported outcome measures are needed to confirm clinical meaningfulness, durability, and rare or late‑onset adverse events.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.